Submitted by Anonymous (not verified) on 14 April 2025 - 9:19
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 7, Status: Authorised